HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI).

Abstract
Traumatic brain injury (TBI) is a leading cause of death worldwide, for which there is currently no comprehensive treatment available. Preventing blood-brain barrier (BBB) disruption is crucial for TBI treatment. N-acylethanolamine acid amidase (NAAA)-regulated palmitoylethanolamide (PEA) signaling play an important role in the control of inflammation. However, the role of NAAA in BBB dysfunction following TBI remains unclear. In the present study, we found that TBI induces the increase of PEA levels in the injured cortex, which prevent the disruption of BBB after TBI. TBI also induces the infiltration of NAAA-contained neutrophils, increasing the contribution of NAAA to the PEA degradation. Neutrophil-derived NAAA weakens PEA/PPARĪ±-mediated BBB protective effects after TBI, facilitates the accumulation of immune cells, leading to secondary expansion of tissue injury. Inactivation of NAAA increased PEA levels in injured site, prevents early BBB damage and improves secondary injury, thereby eliciting long-term functional improvements after TBI. This study identified a new role of NAAA in TBI, suggesting that NAAA is a new important target for BBB dysfunction related CNS diseases.
AuthorsYitian Li, Pan Zhou, Ting Hu, Jie Ren, Yaping Xu, Yan Qiu, Canzhong Lu, Yuhang Li
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 912 Pg. 174561 (Dec 05 2021) ISSN: 1879-0712 [Electronic] Netherlands
PMID34655598 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Elsevier B.V. All rights reserved.
Chemical References
  • 3-(6-phenylhexanoyl)oxazolidin-2-one
  • Amides
  • Enzyme Inhibitors
  • Ethanolamines
  • Neuroprotective Agents
  • Oxazolidinones
  • PPAR alpha
  • Palmitic Acids
  • Ppara protein, mouse
  • palmidrol
  • Amidohydrolases
  • NAAA protein, mouse
Topics
  • Amides (metabolism)
  • Amidohydrolases (antagonists & inhibitors, metabolism)
  • Animals
  • Blood-Brain Barrier (drug effects, metabolism)
  • Brain Injuries, Traumatic (blood, metabolism, pathology)
  • Cell Line
  • Disease Models, Animal
  • Endothelial Cells (drug effects)
  • Enzyme Inhibitors (pharmacology, therapeutic use)
  • Ethanolamines (metabolism)
  • Female
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Neurons (drug effects, metabolism)
  • Neuroprotective Agents (pharmacology, therapeutic use)
  • Neutrophils (metabolism)
  • Oxazolidinones (pharmacology, therapeutic use)
  • PPAR alpha (deficiency, genetics)
  • Palmitic Acids (metabolism)
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: